Men are less likely than women to seek medical help for infertility, a British study suggests.
Research published in Human Reproduction found that 57.3 percent of women sought help after at least one year of unsuccessful pregnancy attempts. In contrast,...
It is well-established that low socioeconomic status (SES) during childhood can negatively influence health throughout the adult years. Recent research published in Annals of Behavioral Medicine suggests attachment orientation may be a mediator of this phenomenon.
Recent research demonstrates the chief mechanism by which smoking damages sperm.
A causal relationship exists between senescent cells and osteoarthritis (OA) development, according to a recent study in The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. That finding confirms what researchers have long suspected.
A 2012 initiative that Cherokee Nation Health Services (CNHS) in Oklahoma launched to enhance hepatitis C management has yielded significant, positive results among the American Indian population.
With research yielding sometimes discordant findings regarding long-term medical risks of football, physicians are looking for answers for parents concerned about youth participation.
Patients received urgent care of wide-ranging quality via videoconference, telephone or webchat with providers at commercial virtual visit websites, according to research in JAMA Internal Medicine.
A study published in the Journal of Investigative Dermatology links traffic-related air pollution to the formation of lentigines, benign lesions also known as liver spots, on the cheeks of Caucasian women in Germany and Han Chinese women. The findings suggest a...
Studies point to a frequent disconnect between the priorities of clinical investigators and patient and physician end users. Engaging patients and other stakeholders in research prioritization can enhance study relevance and may even shorten the time it takes to bring scientific discoveries from the laboratory to the bedside.
The lack of a medication to treat primary-progressive multiple sclerosis (PPMS) is a source of frustration for clinicians and patients. The results of a recent phase 3 study of the drug ocrelizumab may be cause for hope.
- 1 of 6
- next ›